理邦儀器(300206.SZ)一季度淨利潤預增45%-60%
格隆匯 4 月 7日丨理邦儀器(300206.SZ)公佈,預計2021年第一季度實現營業收入50336.39萬元-52134.12萬元,同比增長40%-45%;歸屬於上市公司股東的淨利潤11797.11萬元-13017.50萬元,同比增長45%-60%;扣除非經常性損益後的淨利潤10857.28萬元-11875.14萬元,同比增長60%-75%。業績變動原因如下:
1、在過去一年多的抗疫過程中,公司針對新冠肺炎疫情為全球醫療機構提供了高品質的產品與服務,大幅提升了“理邦儀器”的品牌知名度。報吿期內,公司與疫情直接相關產品銷售穩步增長,與疫情非直接相關產品銷售快速增長,進而驅動一季度業績整體增長。
2、報吿期公司非經常性損益對淨利潤影響預計為1100萬元左右,主要為政府補助。本期政府補助較上年同期減少250萬元左右。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.